Previous reports indicated that the BMI1 gene may be a novel molecular marker to predict the progression and prognosis of breast cancer and myelodysplastic syndrome (MDS)[19,20,23,24]. This evidence concerns the gene BMI1 and myelodysplastic syndrome.